Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity

J Infect Dis. 1995 Jul;172(1):296-301. doi: 10.1093/infdis/172.1.296.

Abstract

Thirteen patients (median age, 20 years) with life-threatening primary septic shock (10 meningococcal, 3 pneumococcal infections) were studied prospectively. All had a short history of sepsis (< or = 24 h) and no severe underlying disease. Two (15%) died. The logarithm of the initial plasma levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6, IL-1 receptor antagonist (ra), and plasminogen activator inhibitor (PAI)-1 correlated significantly with APACHE II scores (r2 = .67, .57, .68, .81, and .68, respectively). The plasma levels of endotoxin, TNF-alpha, IL-1 beta, and PAI-1 decreased toward normal levels within the first 24 h of treatment, but IL-6 and IL-1ra levels remained high until clinical recovery. On admission, the molar excess of IL-1ra to IL-1 beta was > 2000-fold in 11 of the 13 patients. Acute plasmapheresis in 11 of the 13 patients significantly increased the plasma clearance of TNF-alpha (P = .02).

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers / blood
  • Cytokines / blood*
  • Female
  • Humans
  • Insulin Receptor Substrate Proteins
  • Interleukin-1 / blood
  • Interleukin-6 / blood
  • Male
  • Meningococcal Infections / blood
  • Meningococcal Infections / immunology
  • Meningococcal Infections / physiopathology
  • Middle Aged
  • Phosphoproteins / blood
  • Plasminogen Activator Inhibitor 1 / blood
  • Pneumococcal Infections / blood
  • Pneumococcal Infections / immunology
  • Pneumococcal Infections / physiopathology
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Shock, Septic / blood
  • Shock, Septic / immunology*
  • Shock, Septic / physiopathology*
  • Time Factors
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Biomarkers
  • Cytokines
  • IRS1 protein, human
  • Insulin Receptor Substrate Proteins
  • Interleukin-1
  • Interleukin-6
  • Phosphoproteins
  • Plasminogen Activator Inhibitor 1
  • Tumor Necrosis Factor-alpha